PROFUND ADVISORS LLC - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 399 filers reported holding ENCOMPASS HEALTH CORP in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q2 2024$235,923
-15.6%
2,750
-18.7%
0.01%
-18.2%
Q1 2024$279,368
+34.1%
3,383
+10.0%
0.01%0.0%
Q2 2023$208,276
-23.1%
3,076
-32.1%
0.01%
-38.9%
Q4 2022$270,939
+30.3%
4,530
-1.5%
0.02%
+20.0%
Q3 2022$208,000
-29.5%
4,597
-12.8%
0.02%
-21.1%
Q2 2022$295,000
-40.2%
5,269
-23.9%
0.02%
-9.5%
Q1 2022$493,000
+32.2%
6,927
+21.4%
0.02%
+75.0%
Q4 2021$373,000
-16.2%
5,708
-3.7%
0.01%
-20.0%
Q3 2021$445,000
-14.4%
5,927
-11.0%
0.02%
-11.8%
Q2 2021$520,000
-4.2%
6,663
+0.5%
0.02%
-19.0%
Q1 2021$543,000
-8.1%
6,629
-7.2%
0.02%
-19.2%
Q4 2020$591,000
+36.2%
7,143
+6.8%
0.03%
+18.2%
Q3 2020$434,000
+20.2%
6,686
+14.8%
0.02%
+10.0%
Q2 2020$361,000
+23.6%
5,825
+27.9%
0.02%
-9.1%
Q1 2020$292,000
-46.3%
4,554
-42.0%
0.02%
-8.3%
Q4 2019$544,000
+5.4%
7,856
-3.6%
0.02%
-7.7%
Q3 2019$516,000
-23.8%
8,149
-23.8%
0.03%
-18.8%
Q2 2019$677,000
-1.5%
10,688
-9.1%
0.03%
-3.0%
Q1 2019$687,000
+33.9%
11,761
+41.5%
0.03%
+3.1%
Q4 2018$513,000
-52.0%
8,313
-39.3%
0.03%
-22.0%
Q3 2018$1,068,000
+9.1%
13,698
-5.3%
0.04%
+5.1%
Q2 2018$979,000
+1.9%
14,462
-14.0%
0.04%
+2.6%
Q1 2018$961,00016,8090.04%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Iron Triangle Partners LP 697,659$45,334,00010.13%
JANA PARTNERS LLC 1,741,513$113,164,00010.12%
Endurant Capital Management LP 276,105$17,941,0005.31%
REINHART PARTNERS, LLC. 726,140$47,184,0003.55%
Prosight Management, LP 107,921$7,013,0003.34%
Advantage Alpha Capital Partners LP 160,234$10,412,0002.41%
RK Capital 115,800$7,525,0002.13%
Copeland Capital Management, LLC 700,015$45,487,0002.02%
Sivik Global Healthcare LLC 65,000$4,224,0001.82%
Walthausen & Co., LLC 120,016$7,799,0001.62%
View complete list of ENCOMPASS HEALTH CORP shareholders